# Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer

> **NCT01977235** · PHASE2 · UNKNOWN · sponsor: **Third Military Medical University** · enrollment: 110 (estimated)

## Conditions studied

- Small Cell Lung Carcinoma

## Interventions

- **DRUG:** Irinotecan
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01977235
- **Lead sponsor:** Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2017-02
- **Final completion:** 2017-09
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2016-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01977235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01977235, "Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01977235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*